PB
| |
Propel Bio Management, LLC13F | |
| Propel Bio Management, LLC | |
| Last update 2025-05-15 | 17 Stocks (2 new) |
| Value $85.00 Mil | Turnover 6 % |
Propel Bio Management, LLC Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PAGP | Plains GP Holdings LP | 1,272,360 | 27,177.6 | 0% | 31.960 | 0% | 0.640 | +11.01% | +8.89% | 3,810.5 | Oil & Gas | |
MDGL | Madrigal Pharmaceuticals Inc | 30,032 | 9,947.5 | -30.21% | 11.700 | -3.98% | 0.140 | -6.88% | -6.29% | 6,420.5 | Biotechnology | |
AKRO | Akero Therapeutics Inc | 228,884 | 9,265.2 | -33.41% | 10.900 | -3.17% | 0.290 | +43.23% | +85.19% | 4,107.1 | Biotechnology | |
PHAT | Phathom Pharmaceuticals Inc | 1,134,927 | 7,116.0 | +14.65% | 8.370 | +1.07% | 1.630 | +77.82% | +6.65% | 604.6 | Biotechnology | |
ACHV | Achieve Life Sciences Inc | 2,453,092 | 6,549.8 | 0% | 7.700 | 0% | 7.070 | -6.97% | -41.19% | 102.8 | Biotechnology | |
APLT | Applied Therapeutics Inc | 11,285,420 | 5,517.4 | +17.37% | 6.490 | +0.96% | 7.970 | -18.15% | -60.80% | 47.5 | Biotechnology | |
RNA | Avidity Biosciences Inc | 178,500 | 5,269.3 | 0% | 6.200 | 0% | 0.150 | +13.03% | -0.96% | 3,471.0 | Biotechnology | |
ABEO | Abeona Therapeutics Inc | 624,022 | 2,970.3 | 0% | 3.490 | 0% | 1.280 | +27.64% | +3.23% | 294.1 | Biotechnology | |
TCRX | TScan Therapeutics Inc | 2,087,139 | 2,880.3 | 0% | 3.390 | 0% | 3.690 | +15.08% | -52.30% | 82.1 | Biotechnology | |
DCTH | Delcath Systems Inc | 177,600 | 2,260.8 | +944.71% | 2.660 | +2.41% | 0.510 | +12.19% | +1.66% | 426.3 | Medical Devices & Instruments |
Propel Bio Management, LLC's Historical Top Holdings Breakdowns
Propel Bio Management, LLC's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
ARDX | Ardelyx Inc | 2025-03-31 | Sold Out Sold Out | -4.79% | 4.91 ($5.37) 6.42 | $4.35 | -18.99% | Sold Out | 0 | -950,947 | |
MDGL | Madrigal Pharmaceuticals Inc | 2025-03-31 | Reduce Reduce | -3.98% | 272.79 ($328.59) 355.88 | $289.17 | -12.00% | Reduce -30.21% | 30,032 | -13,000 | |
AKRO | Akero Therapeutics Inc | 2025-03-31 | Reduce Reduce | -3.17% | 21.87 ($42.39) 57.56 | $51.52 | 21.54% | Reduce -33.41% | 228,884 | -114,845 | |
DCTH | Delcath Systems Inc | 2025-03-31 | Add Add | +2.41% | 11.48 ($14.19) 16.45 | $12.24 | -13.74% | Add 944.71% | 177,600 | 160,600 | |
KYMR | Kymera Therapeutics Inc | 2025-03-31 | Sold Out Sold Out | -2.25% | 27.37 ($36.45) 44.36 | $43.81 | 20.19% | Sold Out | 0 | -56,359 | |
MIST | Milestone Pharmaceuticals Inc | 2025-03-31 | New Buy New Buy | +1.37% | 0.8 ($1.99) 2.41 | $2.17 | 9.05% | New holding | 1,451,557 | 1,451,557 | |
KURA | Kura Oncology Inc | 2025-03-31 | Sold Out Sold Out | -1.12% | 6.6 ($7.79) 9.05 | $5.68 | -27.09% | Sold Out | 0 | -130,000 | |
PHAT | Phathom Pharmaceuticals Inc | 2025-03-31 | Add Add | +1.07% | 4.22 ($6.07) 7.74 | $8.66 | 42.67% | Add 14.65% | 1,134,927 | 145,000 | |
APLT | Applied Therapeutics Inc | 2025-03-31 | Add Add | +0.96% | 0.46 ($0.59) 0.94 | $0.34 | -43.12% | Add 17.37% | 11,285,420 | 1,670,000 | |
CMPX | Compass Therapeutics Inc | 2025-03-31 | New Buy New Buy | +0.51% | 1.4 ($2.66) 3.9 | $2.64 | -0.75% | New holding | 228,317 | 228,317 |
Propel Bio Management, LLC Total Holding History ($B)
Propel Bio Management, LLC's Asset Allocation
Propel Bio Management, LLC Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Propel Bio Management, LLC's Hypothetical Growth since 2025-03-31
Propel Bio Management, LLC's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
Propel Bio Management, LLC's Holdings Heat Map
Size field:
Propel Bio Management, LLC's Holdings Bubble Chart
Propel Bio Management, LLC News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers